This study primarily investigated safety aspects of Galileo Therapy in MS (Multiple Sclerosis) patients. In addition is also investigated the effects of the Galileo Application on power, balance, flexibility and quality of life including Mental Health. The Galileo Therapy was applied over a period of 8 weeks with increasing intensity (15-25Hz, position 2.5-4.5, 5-8 times 1 minute, 3 times per week).
The results show significant increase in Balance (+12,8%), the Functional Reach Tests (+14.2%), power (Timed Walk (10m) +9%, Timed Up & Go Test +10%) and Mental Health (FS-36, +9%). Considering that this was design primarily as a safety study this are very interesting results – especially considering that the maximum time per Galileo session including rest in-between exercises was 15 minutes – another proof for the efficiency of Galileo Therapy. This study is also in line with other results of Galileo Therapy reported in MS patients berichteten (#GRFS132, #GRFS94, #GRFS82).
#GRFS112 #GalileoTherapy #MechanoStimulation #MS #MultipleSclerosis #Balance #Power #MentalHealth #QOL #Flexibility #QualityOfLife
The verdict of our customers: Excellent
4.7 out of 5 stars based on 868 reviews
Since 1996 we support our Galileo® customers worldwide.
Development and production exclusively in Germany.
10-year service guarantee &
5 year warranty for private customers in Germany
Unlimited user support for all Galileo customers.
Efficacy proven by over 500 scientific publications.
Winter vacation
Dear customers,
Our colleagues have been working for you and your wishes all year – now we’re giving them a well-deserved break. From 24.12.2025 to 6.1.2026, we’re swapping phones for Christmas movies and to-do lists for plates of cookies.
However, our contact form remains as vigilant as a Christmas angel – feel free to write to us and we will get back to you on January 7, 2026, when we are back, refreshed and full of energy!
Merry Christmas and a magical new year
Your Galileo Team
You are currently viewing a placeholder content from Vimeo. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More Information